Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Treatment Protocol Increases Survival Of Very Young Infants With Acute Lymphoblastic Leukemia

20.07.2007
A new treatment protocol for infants under one-year with acute lymphoblastic leukaemia (ALL) has shown increased survival compared to conventional regimens. The findings are reported in an Article published in this week’s edition of The Lancet.

ALL in infants aged younger than 12 months is both rare and biologically different from ALL in older children. Although the cure rate in children with ALL has improved from around 10% 40 years ago to 80% currently, this improved cure rate has not been seen in infants under 12-months, where event-free survival (EFS) has been reported in the range 17-45%.

Dr Rob Pieters, Erasmus MC-Sophia Childrens Hospital, Rotterdam, The Netherlands and colleagues did a study of 482 infants from 22 countries aged under one-year – The Interfant-99 trial. The patients were arranged in risk-order following their peripheral blood response to a 7-day prednisone pre-treatment (prednisone is a standard ALL treatment). They were then given a hybrid treatment regimen based on the standard treatment protocol for ALL, incorporating some elements designed for treatment of acute myeloid leukaemia (AML).

With an average follow-up time of just over three years, the researchers found that 58% of patients who received the hybrid treatment were in complete remission, while at four years follow-up 47% had experienced EFS. In previous studies of ALL, EFS has been reported in the range 17-45%. The hybrid treatment protocol did not produce more toxic effects than in previous regimens. The authors say: “Patients treated with our hybrid protocol, and especially those who responded poorly to prednisone, had higher EFS than most reported outcomes for treatment of infant ALL.”

The authors believe that the use of cytarabine in low-dose and high-dose sequential course could have led to the improved outcomes in Interfant-99. In-vitro studies have shown that infant lymphoblasts are highly sensitive to cytarabine.

The authors conclude: “We believe that this hybrid treatment protocol will be used as the standard for continuing international collaborative studies that aim to further improve outcomes for acute lymphoblastic leukaemia in infants.”

In an accompanying Comment, Dr Josep-Maria Ribera and Dr Albert Oriol, Institut Català d’Oncologia-Hospital Universitari Germans Trias I Pujol, Badalona, Spain, say “Despite the good results of the Interfant-99 protocol, there is a long way to go....new strategies, mainly derived from knowledge of the disease at a genomic level, are urgently needed. They will lead to the development of novel agents that will hopefully be integrated within the current cytarabine-based strategies. To achieve this goal, international collaboration must continue in this rare leukaemia.”

Tony Kirby | alfa
Further information:
http://www.thelancet.com/webfiles/images/clusters/thelancet/press_office/Lymphoblastic.pdf

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Hot vibrating gases under the electron spotlight

12.12.2017 | Life Sciences

New silicon structure opens the gate to quantum computers

12.12.2017 | Information Technology

Using drones to estimate crop damage by wild boars

12.12.2017 | Ecology, The Environment and Conservation

VideoLinks
B2B-VideoLinks
More VideoLinks >>>